利用自组装二肽纳米颗粒靶向递送microRNA-199a-3p可有效抑制小鼠肝细胞癌
该研究合成精氨酸α,β-脱氢苯丙氨酸(RΔF)纳米颗粒,经乳糖酸(LA)修饰后靶向递送miR-199a-3p至肝细胞癌。RΔF-LA/miR纳米颗粒在体外使miR-199a-3p水平升高超过500倍,抑制细胞增殖和迁移并诱导凋亡;在荷瘤裸鼠中静脉注射后肿瘤生长下降超过50%,并提高生存率(P < 0.05)。
要点
- RΔF-LA纳米颗粒可稳定压缩miR-199a-3p,粒径约60nm,zeta电位约+2.54mV。
- 体外递送使miR-199a-3p水平升高超过500倍,抑制增殖迁移并诱导凋亡。
- 荷瘤小鼠静脉注射后肿瘤生长下降超过50%,生存率提高(P < 0.05)。
核心结论
- RΔF-LA/miR纳米颗粒显著增强miRNA递送,凸显其作为肝细胞癌治疗手段进一步开发的潜力。
研究设计与样本
- 研究为动物实验与体外细胞实验,合成并表征精氨酸α,β-脱氢苯丙氨酸(RΔF)纳米颗粒,经乳糖酸(LA)修饰后递送miR-199a-3p。
主要发现
- RΔF-LA NPs压缩miR-199a-3p后平均粒径约60nm,zeta电位约+2.54mV,在血清中及抗RNase攻击时稳定。
- RΔF-LA/miR NPs增强细胞摄取并高效递送miR-199a-3p,使miR-199a-3p水平升高超过500倍。
- 升高的miR-199a-3p在体外显著抑制细胞增殖和迁移,诱导细胞凋亡并下调靶基因mTOR。
- 荷瘤裸鼠静脉注射后RΔF-LA/miR NPs显示高肿瘤/低器官比值。
- RΔF-LA/miR NPs治疗小鼠肿瘤生长下降超过50%,与mTOR蛋白表达抑制、肿瘤细胞增殖抑制及生存率提高(P < 0.05)一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hepatocellular carcinoma (HCC) is an aggressive tumor with limited systemic and locoregional modalities of treatment. Although microRNA (miRNA) based therapies have significant potential, their targeted delivery remains a major challenge. miR-199a-3p functions as an important tumor suppressor in HCC, which regulates various cellular processes. Recently, peptide-based nanoparticles (NPs) have been developed to deliver oligonucleotides including miRNA. Here, we describe the synthesis and characterization of arginine α,β-dehydrophenylalanine (RΔF) nanoparticles for the selective delivery of miR-199a-3p to restore dysregulated gene expression in HCC. Targeted delivery was achieved by conjugating lactobionic acid (LA) with RΔF NPs (RΔF-LA NPs), a ligand for the asialoglycoprotein receptor known to be overexpressed in HCC cell lines. RΔF-LA NPs condensed miR-199a-3p had an average size of ∼60nm and a zeta potential of ∼+2.54 mV. RΔF-LA/miR NPs were found to be stable in serum as well as against RNase attack. RΔF-LA/miR NPs showed an enhanced cellular uptake and an efficient delivery of miR-199a-3p leading to a significant increase in miR-199a-3p levels (over 500 fold). The increased miR-199a-3p levels remarkably suppressed cell proliferation and migration as well as induced cellular apoptosis and downregulation of the specific target gene (mTOR) in vitro. RΔF-LA/miR NPs showed high tumor/ low organ ratios after intravenous injection into HCC tumor bearing nude mice. RΔF-LA/miR NPs treated mice demonstrated>50% decline in tumor growth, which also corresponded well with suppression of mTOR protein expression, tumor cell proliferation and increased survival rate (P < 0.05). CONCLUSION: RΔF-LA/miR NPs showed significantly enhanced delivery of the miRNA which underscores their potential for further development as a therapeutic approach for HCC. (Hepatology 2018;67:1392-1407).
引用
- Varshney A, Panda JJ, Singh AK, et al. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Hepatology. 2018. PMID: 29108133. doi:10.1002/hep.29643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。